ArticlePloS one2022

Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors.

Danielle Almeida Braggio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.